<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title42.html">
                                    Title 42
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/42CFR410.html">Part 410
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 410.37  Colorectal cancer screening tests: Conditions for and
                            </h3>
                            <p class="depth1"><em>(a)</em> Definitions. As used in this section, the following definitions  apply:</p><p class="depth2"><em>(1)</em> Colorectal cancer screening tests means any of the following  procedures furnished to an individual for the purpose of early detection  of colorectal cancer:</p><p class="depth3"><em>(i)</em> Screening fecal-occult blood tests.</p><p class="depth3"><em>(ii)</em> Screening flexible sigmoidoscopies.</p><p class="depth3"><em>(iii)</em> Screening colonoscopies, including anesthesia furnished in  conjunction with the service.</p><p class="depth3"><em>(iv)</em> Screening barium enemas.</p><p class="depth3"><em>(v)</em> Other tests or procedures established by a national coverage  determination, and modifications to tests under this paragraph, with  such frequency and payment limits as CMS determines appropriate, in  consultation with appropriate organizations</p><p class="depth2"><em>(2)</em> Screening fecal-occult blood test means--</p><p class="depth3"><em>(i)</em> A guaiac-based test for peroxidase activity, testing two samples  from each of three consecutive stools, or,</p><p class="depth3"><em>(ii)</em> Other tests as determined by the Secretary through a national  coverage determination.</p><p class="depth2"><em>(3)</em> An individual at high risk for colorectal cancer means an  individual with--</p><p class="depth3"><em>(i)</em> A close relative (sibling, parent, or child) who has had  colorectal cancer or an adenomatous polyp;</p><p class="depth3"><em>(ii)</em> A family history of familial adenomatous polyposis;</p><p class="depth3"><em>(iii)</em> A family history of hereditary nonpolyposis colorectal cancer;</p><p class="depth3"><em>(iv)</em> A personal history of adenomatous polyps; or</p><p class="depth3"><em>(v)</em> A personal history of colorectal cancer; or</p><p class="depth3"><em>(vi)</em> Inflammatory bowel disease, including Crohn's Disease, and  ulcerative colitis.</p><p class="depth2"><em>(4)</em> Screening barium enema means--</p><p class="depth3"><em>(i)</em> A screening double contrast barium enema of the entire  colorectum (including a physician's interpretation of the results of the  procedure); or</p><p class="depth3"><em>(ii)</em> In the case of an individual whose attending physician decides  that he or she cannot tolerate a screening double contrast barium enema,  a screening single contrast barium enema of the entire colorectum  (including a physician's interpretation of the results of the  procedure).</p><p class="depth2"><em>(5)</em> An attending physician for purposes of this provision is a  doctor of medicine or osteopathy (as defined in section 1861(r)(1) of  the Act) who is fully knowledgeable about the beneficiary's medical  condition, and who would be responsible using the results of any  examination performed in the overall management of the beneficiary's  specific medical problem.</p><p class="depth1"><em>(b)</em> Condition for coverage of screening fecal-occult blood tests.  Medicare Part B pays for a screening fecal-occult blood test if it is  ordered in writing by the beneficiary's attending physician, physician  assistant, nurse practitioner, or clinical nurse specialist.</p><p class="depth1"><em>(c)</em> Limitations on coverage of screening fecal-occult blood tests.  </p><p class="depth2"><em>(1)</em> Payment may not be made for a screening fecal-occult blood test  performed for an individual under age 50.</p><p class="depth2"><em>(2)</em> For an individual 50 years of age or over, payment may be made  for a screening fecal-occult blood test performed after at least 11  months have passed following the month in which the last screening  fecal-occult blood test was performed.</p><p class="depth1"><em>(d)</em> Condition for coverage of flexible sigmoidoscopy screening.  Medicare Part B pays for a flexible sigmoidoscopy screening service if  it is performed by a doctor of medicine or osteopathy (as defined in  section 1861(r)(1) of the Act), or by a physician assistant, nurse  practitioner, or clinical nurse specialist (as defined in section  1861(aa)(5) of the Act and Sec. Sec. 410.74, 410.75, and 410.76) who is  authorized under State law to perform the examination.</p><p class="depth1"><em>(e)</em> Limitations on coverage of screening flexible sigmoidoscopies.  </p><p class="depth2"><em>(1)</em> Payment may not be made for a screening flexible sigmoidoscopy  performed for an individual under age 50.</p><p class="depth2"><em>(2)</em> For an individual 50 years of age or over, except as described  in paragraph (e)(3) of this section, payment may be made for screening  flexible sigmoidoscopy after at least 47 months have passed following  the month in which the last screening flexible sigmoidoscopy or, as  provided in paragraphs (h) and (i) of this section, the last screening  barium enema was performed.</p><p class="depth2"><em>(3)</em> of this section but  who has had a screening colonoscopy performed, payment may be made for a  screening flexible sigmoidosocopy only after at least 119 months have  passed following the month in which the last screening colonoscopy was  performed.</p><p class="depth1"><em>(f)</em> Condition for coverage of screening colonoscopies. Medicare Part  B pays for a screening colonoscopy if it is performed by a doctor of  medicine or osteopathy (as defined in section 1861(r)(1) of the Act).</p><p class="depth1"><em>(g)</em> Limitations on coverage of screening colonoscopies. </p><p class="depth2"><em>(1)</em>  Effective for services furnished on or after July 1, 2001, except as  described in paragraph (g)(3) of this section, payment may be made for a  screening colonoscopy performed for an individual who is not at high  risk for colorectal cancer as described in paragraph (a)(3) of this  section, after at least 119 months have passed following the month in  which the last screening colonoscopy was performed.</p><p class="depth2"><em>(2)</em> Payment may be made for a screening colonoscopy performed for an  individual who is at high risk for colorectal cancer as described in  paragraph (a)(3) of this section, after at least 23 months have passed  following the month in which the last screening colonoscopy was  performed, or, as provided in paragraphs (h) and (i) of this section,  the last screening barium enema was performed.</p><p class="depth2"><em>(3)</em> of this section but  who has had a screening flexible sigmoidoscopy performed, payment may be  made for a screening   colonoscopy only after at least 47 months have passed following the  month in which the last screening flexible sigmoidoscopy was performed.</p><p class="depth1"><em>(h)</em> Conditions for coverage of screening barium enemas. Medicare  Part B pays for a screening barium enema if it is ordered in writing by  the beneficiary's attending physician.</p><p class="depth1"><em>(i)</em> Limitations on coverage of screening barium enemas. </p><p class="depth2"><em>(1)</em> In the  case of an individual age 50 or over who is not at high risk of  colorectal cancer, payment may be made for a screening barium enema  examination performed after at least 47 months have passed following the  month in which the last screening barium enema or screening flexible  sigmoidoscopy was performed.</p><p class="depth2"><em>(2)</em> In the case of an individual who is at high risk for colorectal  cancer, payment may be made for a screening barium enema examination  performed after at least 23 months have passed following the month in  which the last screening barium enema or the last screening colonoscopy  was performed.  [62 FR 59100, Oct. 31, 1997, as amended at 66 FR 55329, Nov. 1, 2001; 67  FR 80040, Dec. 31, 2002; 77 FR 69362, Nov. 16, 2012; 78 FR 74811, Dec.  10, 2013; 79 FR 68002, Nov. 13, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
